Finanzwire Finanzwire
Basculer en Français
10467 Companies
220267 Keywords
149592 Articles
116458 Press releases
Headlines Articles Press releases Tanvex BioPharma USA, Inc. Remove
  1. Home
  2. Companies
  3. Tanvex BioPharma USA, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 08/19/2024 at 13:05, 1 year 9 months ago

    Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05

    FDA Approval Cancer Treatment Healthcare Innovation Biosimilar Neutropenia
  • PRESS RELEASE

    published on 08/19/2024 at 13:00, 1 year 9 months ago

    Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05

    Tanvex BioPharma USA, Inc. receives FDA approval for NYPOZI™ biosimilar and FDA BLA acceptance for TX-05, showcasing expertise in biologics development and manufacturing
    FDA Approval Biologics Tanvex BioPharma NYPOZI TX-05
    Logo of Tanvex BioPharma USA, Inc.
  • PRESS RELEASE

    published on 10/16/2023 at 14:00, 2 years 7 months ago

    Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars

    Logo of Tanvex BioPharma USA, Inc.
Accesswire
  • Published on 05/28/2026 at 18:10, 45 minutes ago

    GGL Resources Corp. Announces Receipt of Upfront Cash Payment and Shares from Nelson Resources Limited and Adoption of Semi-Annual Reporting

  • Published on 05/28/2026 at 17:45, 1 hour 10 minutes ago

    Sky Gold Completes Drilling Program

  • Published on 05/28/2026 at 16:00, 2 hours 55 minutes ago

    Exercise of Options

  • Published on 05/28/2026 at 16:00, 2 hours 55 minutes ago

    Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders

  • Published on 05/28/2026 at 15:40, 3 hours 15 minutes ago

    Galantas Gold Completes $100 Million Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 05/28/2026 at 18:40, 15 minutes ago

    Following Sanctions-Risk Information from Western Partners, the Ministry of Justice of the Kyrgyz Republic Suspends 50 Legal Entities in First-Ever Use of Interagency Law to Crack Down on Malign Foreign Economic Activity

  • Published on 05/28/2026 at 18:32, 23 minutes ago

    CPI PROPERTY GROUP – Annual and Extraordinary General Meetings of Shareholders

  • Published on 05/28/2026 at 18:05, 50 minutes ago

    4finance Holding S.A. reports results for the three months ending 31 March 2026

  • Published on 05/28/2026 at 18:03, 51 minutes ago

    CPI Europe announces unaudited results for the first quarter of 2026

  • Published on 05/28/2026 at 17:45, 1 hour 10 minutes ago

    CTS EVENTIM continues on its growth course in the first quarter of 2026

View all EQS
Les Echos
  • Published on 05/28/2026 at 18:34, 21 minutes ago

    LNA SANTE : Expanding hospital at home in Ile-de-France region

  • Published on 05/28/2026 at 18:06, 48 minutes ago

    Net profit and EBITDA up driven by the recovery in volumes and improvement in unit margins in the Recycling business. Upgrade in outlook

  • Published on 05/28/2026 at 18:00, 55 minutes ago

    Revenues for fiscal year 2025/2026

  • Published on 05/28/2026 at 17:50, 1 hour 5 minutes ago

    Press release relating to the availability of the preparatory documents – GM of 18 June 2026

  • Published on 05/28/2026 at 17:45, 1 hour 10 minutes ago

    EURAZEO ACQUIRES T1A GROUP IN DENMARK TO ACCELERATE THE CIRCULAR ECONOMY IN THE IT SECTOR

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy